Frequently Asked Questions How large is the demand for GLP-1 receptor agonists in the global market in 2026
Purity and sterility are essential for safe treatment
Yeast phosphopeptides were mixed at 0.1%, 1%, 10%, 50%, 90%, 99%, and 99.9% into dephosphorylated peptides at 99.9%, 99%, 90%, 50%, 10%, 1%, and 0.1%, with the total amount of peptides per condition corresponding to Ti-IMAC enrichment from 200 g yeast starting material
Beyond direct pancreatic effects, GLP-1 therapy is associated with improved insulin sensitivity in peripheral tissues, particularly skeletal muscle and adipose tissue
Store in a sealed, shaded container at room temperature